Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$336K Buy
665
+45
+7% +$23.3K 0.01% 953
2026
Q2
$289K Buy
620
+371
+149% +$156K 0.01% 1001
2026
Q1
$94.1K Sell
249
-41
-14% -$17.6K ﹤0.01% 1721
2025
Q4
$124K Buy
290
+114
+65% +$49.6K 0.01% 1416
2025
Q3
$78.8K Sell
176
-59
-25% -$26.7K ﹤0.01% 1679
2025
Q2
$114K Sell
235
-36
-13% -$20.5K 0.01% 1333
2025
Q1
$167K Buy
271
+144
+113% +$81.8K 0.01% 873
2024
Q4
$67.3K Sell
127
-11
-8% -$6.2K 0.01% 1412
2024
Q3
$82.9K Buy
138
+52
+60% +$29.5K 0.01% 1124
2024
Q2
$46.7K Buy
86
+22
+34% +$12.6K 0.01% 1245
2024
Q1
$41.1K Buy
64
+2
+3% +$1.22K 0.01% 1171
2023
Q4
$36.8K Buy
+62
New +$34.7K 0.01% 1093

Other funds holding CHE

GAMMA Investing's CHE Position: Q3 2026 in Review

GAMMA Investing increased its Chemed (CHE) stake by 7.3% in Q3 2026, buying an estimated $23.3K and bringing the position to 665 shares worth $336K. The position accounts for 0.01% of the portfolio, ranked #953.

GAMMA Investing first reported a position in CHE in Q4 2023 and has held it in 12 quarters since. 16 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • GAMMA Investing held 665 shares of Chemed worth $336K as of Q3 2026.
  • GAMMA Investing bought 45 Chemed shares in Q3 2026, an estimated $23.3K.
  • Chemed made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #953 holding.
  • GAMMA Investing first reported a position in Chemed in Q4 2023 and has held it in 12 quarters since.
  • 16 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.